Stock Movers: Palantir Slides, Vertex Pharmaceuticals Misses, DoorDash Acquires

Palantir's AI Software Demand

• 📉 Palantir Technologies shares experienced their largest decline in nearly a year, falling as much as 15%.
• 🚀 Despite a "ravenous whirlwind" of demand for its artificial intelligence software, the company's results and projections did not meet Wall Street's high expectations.
• 📈 The company did raise its 2025 revenue forecast to approximately $3.9 billion from $3.75 billion, yet the stock still declined.

Vertex Pharmaceuticals' Earnings Miss

• 💊 Vertex Pharmaceuticals saw its shares tumble, marking its worst day since December, down as much as 14%.
• 📊 The company's first-quarter earnings missed expectations, with only 20,000 prescriptions filled for its non-opioid pain drug.
• ⚠️ Analysts are divided on the launch of its new medications, particularly regarding gaining backing from insurance companies.

DoorDash's Strategic Acquisitions

• 🛒 DoorDash shares dropped despite reporting better-than-expected first-quarter gross order value and issuing a strong outlook.
• 🤝 The company announced two significant acquisitions: London-based Deliveroo Plc for £2.9 billion and hospitality tech firm SevenRooms Inc. for $1.2 billion.
• 💳 Personal anecdote highlights DoorDash's appeal through credit card perks, alongside a trend towards home cooking.